Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)

Clinical trial NCT00307229 · COMPLETED

Trial details

NCT number: NCT00307229
Sponsor: Ontario Clinical Oncology Group (OCOG)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer Recurrent Breast Cancer

Start date: 2006-03-01
Primary completion: 2009-07-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.